Study of chronic hepatitis risk in people with immune weaknesses
Part of Digestive system, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at people with certain immune system weaknesses to see if they are at risk for chronic hepatitis caused by a virus in the gut. Researchers want to understand how the immune system affects this infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated at a specific hospital in Paris (Necker, Saint-Louis, or Cochin).
- You have a type of immune system problem, such as a primary immunodeficiency, a secondary immunodeficiency from certain treatments, combined immunodeficiency, or severe combined immunodeficiency treated more than 2 years ago.
- You or your legal guardian agree to take part in the study.
- You are not excluded if you have an immune condition not listed above.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children and adults with SCID and related immune disorders to understand how the illness behaves over time. It also helps researchers learn which testing results and genetic types of SCID match different treatment plans.
This study is for adults whose immune system has trouble fighting viruses due to specific antibodies or a genetic condition. Researchers want to follow these people over time to better understand the condition and improve care.
This trial tests a tool (a way of collecting health information) to help doctors make better diagnosis, prognosis, and treatment decisions for children with certain immune problems. It also includes healthy children (like relatives) as comparison groups, to see how well the tool works.
This study aims to better understand primary immune disorders by collecting genetic and blood (and related) information. It may help researchers identify what causes these conditions and improve future testing and care.
This study collects blood (and sometimes related samples) to learn how genes and the immune system work in people with primary immunodeficiency (PID) or in family members who may not have it. The goal is to improve understanding of rare immune conditions and help guide future care.
This study looks at children who may have inborn errors of immunity, which are problems with the immune system that make it hard to fight infections. The trial tracks children with certain warning signs to learn more about these conditions.
Hear when a new Severe Combined Immunodeficiency (SCID) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.